摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-乙酰基-4-溴-3,5-二甲基苯胺 | 64835-48-9

中文名称
N-乙酰基-4-溴-3,5-二甲基苯胺
中文别名
——
英文名称
N-(4-bromo-3,5-dimethylphenyl)acetamide
英文别名
N-acetyl-3,5-dimethyl-4-bromoaniline;4-bromo-3,5-dimethylacetanilide;N-(4-bromo-3,5-dimethyl-phenyl)-acetamide;5-Acetylamino-2-brom-m-xylol
N-乙酰基-4-溴-3,5-二甲基苯胺化学式
CAS
64835-48-9
化学式
C10H12BrNO
mdl
——
分子量
242.115
InChiKey
HXXWQYBIQBWFDI-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    180-181 °C(Solv: ethanol (64-17-5); water (7732-18-5))
  • 沸点:
    350.6±30.0 °C(Predicted)
  • 密度:
    1.413±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.3
  • 重原子数:
    13
  • 可旋转键数:
    1
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    29.1
  • 氢给体数:
    1
  • 氢受体数:
    1

安全信息

  • 海关编码:
    2924299090

SDS

SDS:ba68c558e670ed148889ef9010dfaf34
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: N-Acetyl 4-bromo-3,5-dimethylaniline
Synonyms: N-(4-Bromo-3,5-dimethylphenyl)acetamide

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: N-Acetyl 4-bromo-3,5-dimethylaniline
CAS number: 64835-48-9

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C10H12BrNO
Molecular weight: 242.1

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen bromide.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    N-乙酰基-4-溴-3,5-二甲基苯胺盐酸sodium hydroxide 、 sodium nitrite 作用下, 以 乙醇 为溶剂, 反应 7.25h, 生成 2-溴-5-碘-1,3-二甲苯
    参考文献:
    名称:
    Bifunctional Pincer-type Organometallics as Substrates for Organic Transformations and as Novel Building Blocks for Polymetallic Materials
    摘要:
    The reactivity of the bifunctionalized ligand NC(Br)N\ 1 [IC6H2(CH2NMe2)(2)-3,5-Br-4] has been studied as a versatile synthon for organic and/or organometallic synthesis. Chemoselective metalation (M = Pd, Pt, LI) at the C-aryl-1 or C-aryl-Br bonds was achieved by choosing the appropriate metal precursors. In this way a series of Pt-II and Pd-II complexes were prepared that have a second functional group available for further reactions. These Pt-II and Pd-II complexes were subjected to a wide range of organic and organometallic reactions, revealing the remarkable stability of their M-C sigma-bond and opening an easy route for the synthesis of mono- and (hetero)bimetallic building blocks. The scope of the chemistry of such building blocks shows that they are good candidates for use in the synthesis of dendrimers, bioorganometallic systems, or polymetallic materials. The X-ray crystal structures of the most representative complexes (2, 3a, 19, 20, and 24) are also reported.
    DOI:
    10.1021/ja0177657
  • 作为产物:
    描述:
    5-硝基间二甲苯 在 palladium 10% on activated carbon 正丁基锂氢气 作用下, 以 四氢呋喃甲醇正己烷二氯甲烷 为溶剂, 反应 21.58h, 生成 N-乙酰基-4-溴-3,5-二甲基苯胺
    参考文献:
    名称:
    ORGANIC COMPOUNDS
    摘要:
    本发明提供了以下结构的化合物;A-L1-B-C-D,这些化合物对于治疗或预防与动物(尤其是人类)中DGAT1活性相关的疾病或疾病非常有用。
    公开号:
    US20110046133A1
点击查看最新优质反应信息

文献信息

  • Combining Eosin Y with Selectfluor: A Regioselective Brominating System for <i>Para</i>-Bromination of Aniline Derivatives
    作者:Binbin Huang、Yating Zhao、Chao Yang、Yuan Gao、Wujiong Xia
    DOI:10.1021/acs.orglett.7b01427
    日期:2017.7.21
    A mild, metal-free, and absolutely para-selective bromination of aniline derivatives has been developed in excellent yields, wherein the organic dye Eosin Y is employed as the bromine source in company with Selectfluor. Neither air nor moisture sensitive, this facile reaction proceeds smoothly at room temperature and completes within a short time. Mechanistic studies indicate a radical pathway; therefore
    已开发出具有优异收率的温和,无属且绝对对位选择性的苯胺生物化物,其中有机染料曙红Y与Selectfluor一起用作源。无论是对空气还是对湿气都不敏感,这种反应很容易在室温下进行并在短时间内完成。机理研究表明了一条根本途径。因此,的原位产生的化试剂的存在,“Selectbrom”,是假设,可合理解释为独特区域选择性段的-bromination Ñ -acyl-以及Ñ -sulfonylanilines。
  • Aryl sulfonamide and sulfonyl compounds as modulators of PPAR and methods of treating metabolic disorders
    申请人:Zhao Cunxiang
    公开号:US20050234046A1
    公开(公告)日:2005-10-20
    Aryl sulfonamide and sulfonyl compounds as modulators of peroxisome proliferator activated receptors, pharmaceutical compositions comprising the same, and methods of treating disease using the same are disclosed.
    芳基磺酰胺和磺酰基化合物作为过氧化物酶体增殖激活受体的调节剂,包含它们的药物组合物,以及使用它们治疗疾病的方法被披露。
  • Halogenation Using Quaternary Ammonium Polyhalides. XI. Bromination of Acetanilides by Use of Tetraalkylammonium Polyhalides
    作者:Shoji Kajigaeshi、Takaaki Kakinami、Hiromichi Yamasaki、Shizuo Fujisaki、Tsuyoshi Okamoto
    DOI:10.1246/bcsj.61.2681
    日期:1988.7
    The reaction of acetanilides with tetraalkylammonium polyhalides, such as tetrabutylammonium tribromide, benzyltrimethylammonium tribromide, and benzyltrimethylammonium chlorobromate(1–), in dichloromethane-methanol at room temperature gave bromosubstituted acetanilides in good yields, respectively.
    乙酰苯胺与四烷基多卤化(如四丁基三溴化铵苄基三甲基三溴化铵苄基甲基氯溴酸(1-))在二氯甲烷-甲醇中在室温下反应,分别以良好的收率得到取代的乙酰苯胺。
  • Organic compounds
    申请人:Novartis AG
    公开号:US08222248B2
    公开(公告)日:2012-07-17
    The present invention provides compounds of the following structure; A-L1-B—C-D that are useful for treating or preventing conditions or disorders associated with DGAT1 activity in animals, particularly humans.
    本发明提供了以下结构的化合物;A-L1-B—C-D,用于治疗或预防与动物,特别是人类DGAT1活性相关的病症或疾病。
  • Spiroimidazolone derivative
    申请人:Esaki Toru
    公开号:US09169254B2
    公开(公告)日:2015-10-27
    The present invention relates to a compound represented by the following formula (1): wherein W, X, Y, R1, R2, R33, R34, m and n are as defined in the claims, or a pharmacologically acceptable salt thereof.
    本发明涉及一种由以下式(1)表示的化合物:其中W、X、Y、R1、R2、R33、R34、m和n如权利要求中所定义,或其药学上可接受的盐。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫